CAS 1334493-07-0

Formel: C29H27F5N2O6S

InChl: InChI=1S/C29H27F5N2O6S/c1-35(43(41,42)28-26(33)24(31)23(30)25(32)27(28)34)15-22(38)36(19-11-12-20(29(39)40)21(37)13-19)14-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h7-13,17,37H,2-6,14-15H2,1H3,(H,39,40)

InChI Key: WNVSFFVDMUSXSX-UHFFFAOYSA-N

SMILES: CN(CC(=O)N(CC1=CC=C(C=C1)C2CCCCC2)C3=CC(=C(C=C3)C(=O)O)O)S(=O)(=O)C4=C(C(=C(C(=C4F)F)F)F)F

BP-1-102

CAS: 1334493-07-0

BP-1-102

Formel: C₂₉H₂₇F₅N₂O₆S

Reinheit: ≥98%

Farbe und Form: Solid

Molekulargewicht: 626.59

Ref: 54-BUP02850

4-(N-(4-Cyclohexylbenzyl)-2-((2,3,4,5,6-pentafluoro-N-methylphenyl)sulfonamido)acetamido)-2-hydroxybenzoic acid

CAS: 1334493-07-0

Formel: C₂₉H₂₇F₅N₂O₆S

Reinheit: %

Farbe und Form: Solid

Molekulargewicht: 626.5915

Ref: IN-DA01A2GD

BP-1-102

CAS: 1334493-07-0

4-(N-(4-Cyclohexylbenzyl)-2-((2,3,4,5,6-pentafluoro-N-methylphenyl)sulfonamido)acetamido)-2-hydroxybenzoic acid

Formel: C₂₉H₂₇F₅N₂O₆S

Reinheit: 99+%

Molekulargewicht: 626.59

Ref: IN-DG559709

BP-1-102

CAS: 1334493-07-0

BP-1-102 is an orally active, effective and specific STAT3 inhibitor.

Formel: C₂₉H₂₇F₅N₂O₆S

Reinheit: 99.25% - 99.44%

Farbe und Form: White Solid

Molekulargewicht: 626.591

Ref: TM-T3708

BP 1-102

CAS: 1334493-07-0

BP 1-102 is a monoclonal antibody that targets PD-L1. It binds to PD-L1, blocking the interaction between PD-L1 and its ligands such as PD-1, B7-H3, and B7-H4. This prevents the inhibitory signals from reaching T cells and other immune cells, leading to an increase in T cell proliferation and activation. BP 1-102 has been shown to have minimal toxicity in animal studies. The drug was well tolerated with no significant changes in body weight or organ weight measurements. BP 1-102 also showed efficacy in preclinical models of cancer by inhibiting tumor growth and increasing cancer cell death (apoptosis). In addition, BP 1-102 has been shown to have an anti-inflammatory effect on IL17a production by T cells.

Formel: C₂₉H₂₇F₅N₂O₆S

Reinheit: Min. 95%

Molekulargewicht: 626.59 g/mol

Ref: 3D-JDC49307